
	At March 31, 2026	At December 31, 2025
(in millions of U.S. dollars)	Current	Current
Trade receivables - gross	856	614
Allowance for credit losses	(3)	(3)
Total trade receivables - net	853	611
Total other receivables	152	112
Total trade receivables and other	1,005	723

The Group has entered into several accounts receivable factoring programs with selected financial institutions for certain

receivables of the Group. The programs are accounted for as sales of the receivables and had combined limits of approximately

$717 million and $729 million at March 31, 2026 and December 31, 2025, respectively.

Proceeds on receivables sold under our ongoing factoring programs were $964 million and $747 million for the three

months ended March 31, 2026 and 2025, respectively. At March 31, 2026 and December 31, 2025, the total amount of

receivables derecognized under the Group’s factoring arrangements was $430 million and $430 million, respectively.

Starting in fiscal year 2025, the proceeds from the sale of accounts receivables comprised of only cash. Prior to January

1, 2025, the proceeds from the sale of certain of these receivables comprised of a combination of cash and deferred purchase

price receivable. The deferred purchase price receivable was ultimately realized by the Group following the collection by the

financial institutions of the underlying receivables sold. For the three months ended March 31, 2025, the beginning deferred

purchase price balance was $2 million, of which $2 million were fully collected in cash. This resulted in an ending deferred

purchase price receivable balance of $0 million for the three months ended March 31, 2025, recorded in Fair value of

derivatives instruments and other financial assets in the consolidated balance sheets.

The Group has recorded $4 million and $5 million of expenses related to its factoring programs in the three months ended

March 31, 2026 and 2025, respectively. These amounts are presented in Other gains and losses – net in its Interim Consolidated